Related Experiment Videos

[BCG osteoarthritis on knee prosthesis after intra-vesical BCG therapy]

P Chazerain1, N Desplaces, J M Ziza

  • 1Service de Médecine Interne et Rhumatologie, Hôpital de la Croix Saint-Simon, Paris.

Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|December 1, 1992
PubMed

Insights

A knee implant infection caused by Calmette-Guérin bacillus (BCG) during therapy resolved favorably after surgery and antitubercular treatment. This septic osteoarthritis case, likely from bloodstream BCG diffusion, differs from reactive polyarthritis.

Area of Science:

  • Infectious Diseases
  • Orthopedic Surgery
  • Immunology

Background:

  • Intravesical Bacillus Calmette-Guérin (BCG) therapy is a standard treatment for superficial bladder cancer.
  • BCG instillation can rarely lead to disseminated infections or reactive inflammatory conditions.
  • Prosthetic joint infections are serious complications requiring prompt diagnosis and management.

Observation:

  • A patient undergoing intravesical BCG therapy developed a knee implant infection.
  • The infection presented as septic osteoarthritis, distinct from reactive polyarthritis.
  • The likely source of infection was hematogenous dissemination of BCG.

Findings:

  • Surgical replacement of the infected knee implant was performed.
  • Antitubercular agents were administered to treat the BCG infection.
  • The patient experienced a favorable clinical outcome following treatment.

Implications:

  • This case highlights the potential for hematogenous spread of BCG to orthopedic implants during therapy.
  • Early recognition and aggressive management, including implant revision and antimicrobial therapy, are crucial for favorable outcomes.
  • Distinguishing BCG-induced septic arthritis from reactive polyarthritis is important for appropriate treatment strategies.

Related Concept Videos